Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer. The approval is for the use of ...

Fact checked by Jennifer Klump Many people try to urinate "just in case" before heading out the door or sitting down to watch a movie. While that's fine occasionally, doing it too often can train your ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Anktiva (nogapendekin alfa inbakicept) for adults with BCG-unresponsive non-muscle invasive bladder cancer, where ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 July 2025, approved nogapendekin alfa inbakicept (Anktiva) for adults with ...

Paula Radcliffe has opened up about “dismissing” her daughter’s early cancer warning signs. The retired marathon runner’s daughter, Isla, was diagnosed with ovarian cancer when she was 13 after ...